Ernexa Therapeutics Inc.

Ernexa Therapeutics Inc.verified

ERNA

Price:

$1.31

Market Cap:

$10.28M

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Industry

Biotechnology

IPO Date

1991-08-29

Stock Exchange

NASDAQ

Ticker

ERNA

The Enterprise Value as of December 2025 (TTM) for Ernexa Therapeutics Inc. (ERNA) is 7.79M

According to Ernexa Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.79M. This represents a change of -91.83% compared to the average of 95.34M of the last 4 quarters.

Ernexa Therapeutics Inc. (ERNA) Historical Enterprise Value (quarterly & annually)

How has ERNA Enterprise Value performed in the past?

The mean historical Enterprise Value of Ernexa Therapeutics Inc. over the last ten years is 627.06M. The current 7.79M Enterprise Value has changed 24.18% with respect to the historical average. Over the past ten years (40 quarters), ERNA's Enterprise Value was at its highest in in the June 2021 quarter at 11.42B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

627.06M

Median

166.99M

Minimum

79.85M

Maximum

2.69B

Ernexa Therapeutics Inc. (ERNA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ernexa Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.29%

Maximum Annual Enterprise Value = 2.69B

Minimum Annual Increase = -94.80%

Minimum Annual Enterprise Value = 79.85M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024124.19M-30.13%
2023177.75M26.91%
2022140.06M-94.80%
20212.69B15.62%
20202.33B2.29%
201997.70M22.34%
201879.85M-48.89%
2017156.24M-36.35%
2016245.47M9.11%

Ernexa Therapeutics Inc. (ERNA) Average Enterprise Value

How has ERNA Enterprise Value performed in the past?

The current Enterprise Value of Ernexa Therapeutics Inc. (ERNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

147.33M

5-year avg

1.09B

10-year avg

627.06M

Ernexa Therapeutics Inc. (ERNA) Enterprise Value vs. Peers

How is ERNA’s Enterprise Value compared to its peers?

Ernexa Therapeutics Inc.’s Enterprise Value is less than Adaptimmune Therapeutics plc (97.78M), less than MapLight Therapeutics, Inc. (0), less than Lunai Bioworks Inc. (33.22M), greater than ProMIS Neurosciences, Inc. (-5422421.00), greater than Dogwood Therapeutics, Inc. (1.78M), greater than BiomX Inc. (5.96M), greater than Moleculin Biotech, Inc. (3.01M), less than AEON Biopharma, Inc. (20.80M), less than OSR Holdings, Inc. (15.64M), greater than Aethlon Medical, Inc. (-3180829199.00),

Build a custom stock screener for Ernexa Therapeutics Inc. (ERNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ernexa Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ernexa Therapeutics Inc. (ERNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ernexa Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Ernexa Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Ernexa Therapeutics Inc. (ERNA)?

What is the 3-year average Enterprise Value for Ernexa Therapeutics Inc. (ERNA)?

What is the 5-year average Enterprise Value for Ernexa Therapeutics Inc. (ERNA)?

How does the current Enterprise Value for Ernexa Therapeutics Inc. (ERNA) compare to its historical average?